Stem Cell Treatment For Macular Degeneration In U S

Stem cell research for age related macular degeneration.

Stem cell treatment for macular degeneration in u s.

Researchers at the national eye institute nei are launching a clinical trial to test the safety of a novel patient specific stem cell based therapy to treat geographic atrophy the advanced dry form of age related macular degeneration amd a leading cause of vision loss among people age 65 and older. Erik eye hospital in sweden have entered into a collaboration with novo nordisk a s to develop a new treatment for age related macular degeneration. There is great potential for stem cell transplantation in age related macular degeneration amd and this article explores the latest research. Researchers in california expect to launch a phase 2 clinical trial of stem cell therapy for age related macular degeneration this year while a team from the national institutes of health is not.

Both patients had end stage disease with severe central vision loss. The other patient had stargardt s macular dystrophy a rare hereditary disease that causes macular degeneration in adolescence. Karolinska institutet and st. Stem cell transplantation to treat macular degeneration.

In the study researchers developed stem cells into cell types found within the eye and carefully injected the cells into specific locations within. Patients with age related macular degeneration amd often ask whether stem cell therapy might improve their vision now or at some point in the future. The promise of using stem cells to combat age related macular degeneration and the demand for it was sufficient to launch an ambitious fundraising effort in 2014 at cu that resulted in successfully recruiting canto soler and creating cellsight. In a dramatic development research is underway to use induced pluri potent stem cells for the treatment of macular degeneration because these cells would be made from the same person eliminating the need for immuno suppressive drugs as well as any religious objections.